Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms (original) (raw)

• Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics, 2010. CA Cancer J. Clin. 60, 277–300 (2010).
  Article PubMed Google Scholar
• Medzhitov, R. Origin and physiological roles of inflammation. Nature 454, 428–435 (2008).
  Article CAS PubMed Google Scholar
• Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650–1659 (1986).
  Article CAS PubMed Google Scholar
• Virchow, R. An address on the value of pathological experiments. Br. Med. J. 2, 198–203 (1881). This is the first account of inflammatory processes that accompany cancer development in tissues.
  Article CAS PubMed PubMed Central Google Scholar
• Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
  Article CAS PubMed Google Scholar
• Kuper, H., Adami, H. O. & Trichopoulos, D. Infections as a major preventable cause of human cancer. J. Intern. Med. 248, 171–183 (2000).
  Article CAS PubMed Google Scholar
• Grivennikov, S. I. et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491, 254–258 (2012). This paper shows a role for products derived from the commensal microbiota in tumour-induced inflammation and tumour promotion.
  Article CAS PubMed PubMed Central Google Scholar
• Goodwin, A. C. et al. Polyamine catabolism contributes to enterotoxigenic _bacteroides fragilis_-induced colon tumorigenesis. Proc. Natl Acad. Sci. USA 108, 15354–15359 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Abdulamir, A. S., Hafidh, R. R. & Abu Bakar, F. The association of streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J. Exp. Clin. Cancer Res. 30, 11 (2011).
  Article PubMed PubMed Central Google Scholar
• Arthur, J. C. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120–123 (2012). This article shows the genotoxic and tumour-promoting potential of a pathobiont of the commensal microflora that blooms under inflammatory conditions.
  Article CAS PubMed PubMed Central Google Scholar
• Amit, I. et al. A module of negative feedback regulators defines growth factor signaling. Nature Genet. 39, 503–512 (2007).
  Article CAS PubMed Google Scholar
• Mosesson, Y., Mills, G. B. & Yarden, Y. Derailed endocytosis: an emerging feature of cancer. Nature Rev. Cancer 8, 835–850 (2008).
  Article CAS PubMed Google Scholar
• Wilson, T. R. et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 487, 505–509 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Straussman, R. et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487, 500–504 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Prahallad, A. et al. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature 483, 100–103 (2012).
  Article CAS PubMed Google Scholar
• Casaletto, J. B. & McClatchey, A. I. Spatial regulation of receptor tyrosine kinases in development and cancer. Nature Rev. Cancer 12, 387–400 (2012).
  Article CAS Google Scholar
• Fukuda, A. et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 19, 441–455 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Lesina, M. et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 19, 456–469 (2011).
  Article CAS PubMed Google Scholar
• Bollrath, J. et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15, 91–102 (2009).
  Article CAS PubMed Google Scholar
• Grivennikov, S. et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15, 103–113 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Bronte-Tinkew, D. M. et al. Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res. 69, 632–639 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Gao, S. P. et al. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J. Clin. Invest. 117, 3846–3856 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Waldner, M. J., Foersch, S. & Neurath, M. F. Interleukin-6 — a key regulator of colorectal cancer development. Int. J. Biol. Sci. 8, 1248–1253 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, H., Pardoll, D. & Jove, R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nature Rev. Cancer 9, 798–809 (2009).
  Article CAS Google Scholar
• Liang, J. et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell 23, 107–120 (2013).
  Article CAS PubMed Google Scholar
• Park, E. J. et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197–208 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Iliopoulos, D., Hirsch, H. A. & Struhl, K. An epigenetic switch involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139, 693–706 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883–899 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Karin, M. & Greten, F. R. NF-κB: linking inflammation and immunity to cancer development and progression. Nature Rev. Immunol. 5, 749–759 (2005).
  Article CAS Google Scholar
• Ben-Neriah, Y. & Karin, M. Inflammation meets cancer, with NF-κB as the matchmaker. Nature Immunol. 12, 715–723 (2011).
  Article CAS Google Scholar
• Pikarsky, E. et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461–466 (2004).
  Article CAS PubMed Google Scholar
• Greten, F. R. et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285–296 (2004). This paper and reference 31 first showed a connection between inflammation and cancer growth through the transcription factor NF-κB.
  Article CAS PubMed Google Scholar
• Popivanova, B. K. et al. Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest. 118, 560–570 (2008).
  CAS PubMed PubMed Central Google Scholar
• Cataisson, C. et al. IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesis. J. Exp. Med. 209, 1689–1702 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Schiechl, G. et al. Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11bhighGr1low macrophages. J. Clin. Invest. 121, 1692–1708 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Tye, H. et al. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. Cancer Cell 22, 466–478 (2012).
  Article CAS PubMed Google Scholar
• Zenewicz, L. A. et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29, 947–957 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Sonnenberg, G. F., Fouser, L. A. & Artis, D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nature Immunol. 12, 383–390 (2011).
  Article CAS Google Scholar
• Pickert, G. et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206, 1465–1472 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Huber, S. et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491, 259–263 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Jiang, R. et al. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 54, 900–909 (2011).
  Article CAS PubMed Google Scholar
• Park, O. et al. In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology 54, 252–261 (2011).
  Article PubMed CAS Google Scholar
• Schwitalla, S. et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 152, 25–38 (2013).
  Article CAS PubMed Google Scholar
• Myant, K. B. et al. ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell 12, 761–773 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Marotta, L. L. et al. The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24− stem cell-like breast cancer cells in human tumors. J. Clin. Invest. 121, 2723–2735 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Ho, P. L., Lay, E. J., Jian, W., Parra, D. & Chan, K. S. Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer. Cancer Res. 72, 3135–3142 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, J. et al. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc. Natl Acad. Sci. USA 104, 16158–16163 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Scheitz, C. J., Lee, T. S., McDermitt, D. J. & Tumbar, T. Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer. EMBO J. 31, 4124–4139 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Quante, M. et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell 21, 36–51 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Campisi, J. & d'Adda di Fagagna, F. Cellular senescence: when bad things happen to good cells. Nature Rev. Mol. Cell Biol. 8, 729–740 (2007).
  Article CAS Google Scholar
• Xue, W. et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656–660 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Chien, Y. et al. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev. 25, 2125–2136 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kang, T. W. et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547–551 (2011).
  Article CAS PubMed Google Scholar
• Braumuller, H. et al. T-helper-1-cell cytokines drive cancer into senescence. Nature 494, 361–365 (2013).
  Article CAS PubMed Google Scholar
• Pribluda, A. et al. A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer Cell 24, 242–256 (2013).
  Article CAS PubMed Google Scholar
• Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436–444 (2008).
  Article CAS PubMed Google Scholar
• Campregher, C., Luciani, M. G. & Gasche, C. Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13-repeat in colon epithelial cells. Gut 57, 780–787 (2008).
  Article CAS PubMed Google Scholar
• Mills, K. D., Ferguson, D. O. & Alt, F. W. The role of DNA breaks in genomic instability and tumorigenesis. Immunol. Rev. 194, 77–95 (2003).
  Article CAS PubMed Google Scholar
• Takai, A. et al. A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations. Oncogene 28, 469–478 (2009).
  Article CAS PubMed Google Scholar
• Okazaki, I. M., Kotani, A. & Honjo, T. Role of AID in tumorigenesis. Adv. Immunol. 94, 245–273 (2007).
  Article CAS PubMed Google Scholar
• Endo, Y. et al. Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. Gastroenterology 135, 889–898 (2008).
  Article CAS PubMed Google Scholar
• Komori, J. et al. Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma. Hepatology 47, 888–896 (2008).
  Article CAS PubMed Google Scholar
• Colotta, F., Allavena, P., Sica, A., Garlanda, C. & Mantovani, A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30, 1073–1081 (2009).
  Article CAS PubMed Google Scholar
• Schetter, A. J., Heegaard, N. H. & Harris, C. C. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31, 37–49 (2010).
  Article CAS PubMed Google Scholar
• Singh, B., Vincent, L., Berry, J. A., Multani, A. S. & Lucci, A. Cyclooxygenase-2 expression induces genomic instability in MCF10A breast epithelial cells. J. Surg. Res. 140, 220–226 (2007).
  Article CAS PubMed Google Scholar
• Hahn, M. A. et al. Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res. 68, 10280–10289 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Mishra, A. et al. Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. Cancer Cell 22, 645–655 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Talmadge, J. E. & Fidler, I. J. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res. 70, 5649–5669 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Peinado, H., Lavotshkin, S. & Lyden, D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin. Cancer Biol. 21, 139–146 (2011).
  Article CAS PubMed Google Scholar
• Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39–51 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420–1428 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Bates, R. C. & Mercurio, A. M. Tumor necrosis factor-α stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol. Biol. Cell 14, 1790–1800 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Sullivan, N. J. et al. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 28, 2940–2947 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, Y. et al. Stabilization of snail by NF-κB is required for inflammation-induced cell migration and invasion. Cancer Cell 15, 416–428 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Voronov, E. et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl Acad. Sci. USA 100, 2645–2650 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Grivennikov, S. I. & Karin, M. Inflammation and oncogenesis: a vicious connection. Curr. Opin. Genet. Dev. 20, 65–71 (2010).
  Article CAS PubMed Google Scholar
• Gocheva, V. et al. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 24, 241–255 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• DeNardo, D. G. et al. CD4+ T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16, 91–102 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kitamura, T. et al. SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion. Nature Genet. 39, 467–475 (2007).
  Article CAS PubMed Google Scholar
• Murdoch, C., Muthana, M., Coffelt, S. B. & Lewis, C. E. The role of myeloid cells in the promotion of tumour angiogenesis. Nature Rev. Cancer 8, 618–631 (2008).
  Article CAS Google Scholar
• Lerner, I. et al. Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice. J. Clin. Invest. 121, 1709–1721 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Wyckoff, J. B. et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 67, 2649–2656 (2007).
  Article CAS PubMed Google Scholar
• Grivennikov, S. I., Kuprash, D. V., Liu, Z. G. & Nedospasov, S. A. Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms. Int. Rev. Cytol. 252, 129–161 (2006).
  Article CAS PubMed Google Scholar
• Nguyen, D. X., Bos, P. D. & Massague, J. Metastasis: from dissemination to organ-specific colonization. Nature Rev. Cancer 9, 274–284 (2009).
  Article CAS Google Scholar
• McDonald, B. et al. Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms. Int. J. Cancer 125, 1298–1305 (2009).
  Article CAS PubMed Google Scholar
• Chen, J. et al. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell 19, 541–555 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Qian, B. Z. et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475, 222–225 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Wolf, M. J. et al. Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell 22, 91–105 (2012).
  Article CAS PubMed Google Scholar
• Motz, G. T. & Coukos, G. Deciphering and reversing tumor immune suppression. Immunity 39, 61–73 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Robbins, P. F. et al. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nature Med. 19, 747–752 (2013).
  Article CAS PubMed Google Scholar
• Gabrilovich, D. I. et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med. 2, 1096–1103 (1996).
  Article CAS PubMed Google Scholar
• Curiel, T. J. et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nature Med. 9, 562–567 (2003).
  Article CAS PubMed Google Scholar
• Geissmann, F. et al. TGF-β 1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 162, 4567–4575 (1999).
  CAS PubMed Google Scholar
• Steinbrink, K. et al. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8+ T cells resulting in a failure to lyse tumor cells. Blood 93, 1634–1642 (1999).
  CAS PubMed Google Scholar
• Menetrier-Caux, C. et al. Inhibition of the differentiation of dendritic cells from CD34+ progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92, 4778–4791 (1998).
  CAS PubMed Google Scholar
• Bayne, L. J. et al. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21, 822–835 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Gabrilovich, D. I. & Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nature Rev. Immunol. 9, 162–174 (2009).
  Article CAS Google Scholar
• Curiel, T. J. et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Med. 10, 942–949 (2004).
  Article CAS PubMed Google Scholar
• Facciabene, A. et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells. Nature 475, 226–230 (2011).
  Article CAS PubMed Google Scholar
• Facciabene, A., Motz, G. T. & Coukos, G. T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res. 72, 2162–2171 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Zarek, P. E. et al. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111, 251–259 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Garrett, W. S. et al. Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell 16, 208–219 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Couturier-Maillard, A. et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 123, 700–711 (2013).
  CAS PubMed PubMed Central Google Scholar
• Moore, P. S. & Chang, Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nature Rev. Cancer 10, 878–889 (2010).
  Article CAS Google Scholar
• Russell, W. An address on a characteristic organism of cancer. Br. Med. J. 2, 1356–1360 (1890).
  Article CAS PubMed PubMed Central Google Scholar
• Wuerthele-Caspe, V. et al. Cultural properties and pathogenicity of certain microorganisms obtained from various proliferative and neoplastic diseases. Am. J. Med. Sci. 220, 638–646 (1950).
  Article CAS PubMed Google Scholar
• Livingston, V. W. & Alexander-Jackson, E. An experimental biologic approach to the treatment of neoplastic disease; determination of actinomycin in urine and cultures as an aid to diagnosis and prognosis. J. Am. Med. Womens Assoc. 20, 858–866 (1965).
  CAS PubMed Google Scholar
• Unproven methods of cancer management. Livingston-Wheeler therapy. CA Cancer J. Clin. 41, A7–A12 (1991).
• Polk, D. B. & Peek, R. M. Jr. Helicobacter pylori: gastric cancer and beyond. Nature Rev. Cancer 10, 403–414 (2010).
  Article CAS Google Scholar
• Franco, A. T. et al. Activation of β-catenin by carcinogenic Helicobacter pylori. Proc. Natl Acad. Sci. USA 102, 10646–10651 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Samaras, V., Rafailidis, P. I., Mourtzoukou, E. G., Peppas, G. & Falagas, M. E. Chronic bacterial and parasitic infections and cancer: a review. J. Infect. Dev. Ctries 4, 267–281 (2010).
  Article PubMed Google Scholar
• Hill, M. J. Chronic bacterial infection and subsequent human carcinogenesis. Eur. J. Cancer Prev. 4, 127–128 (1995).
  CAS PubMed Google Scholar
• Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214 (2012).
• Gordon, J. I. Honor thy gut symbionts redux. Science 336, 1251–1253 (2012).
  Article CAS PubMed Google Scholar
• Rakoff-Nahoum, S. & Medzhitov, R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317, 124–127 (2007).
  Article CAS PubMed Google Scholar
• Lee, S. H. et al. ERK activation drives intestinal tumorigenesis in Apcmin/+ mice. Nature Med. 16, 665–670 (2010).
  Article CAS PubMed Google Scholar
• Uronis, J. M. et al. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS ONE 4, e6026 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Salcedo, R. et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J. Exp. Med. 207, 1625–1636 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Fukata, M. et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133, 1869–1881 (2007).
  Article CAS PubMed Google Scholar
• Lowe, E. L. et al. Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer. PLoS ONE 5, e13027 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Elinav, E., Henao-Mejia, J. & Flavell, R. A. Integrative inflammasome activity in the regulation of intestinal mucosal immune responses. Mucosal Immunol. 6, 4–13 (2013).
  Article CAS PubMed Google Scholar
• Hu, B. et al. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc. Natl Acad. Sci. USA 107, 21635–21640 (2010).
  Article PubMed PubMed Central Google Scholar
• Zaki, M. H., Vogel, P., Body-Malapel, M., Lamkanfi, M. & Kanneganti, T. D. IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J. Immunol. 185, 4912–4920 (2010).
  Article CAS PubMed Google Scholar
• Chen, G. Y., Liu, M., Wang, F., Bertin, J. & Nunez, G. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J. Immunol. 186, 7187–7194 (2011).
  Article CAS PubMed Google Scholar
• Normand, S. et al. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc. Natl Acad. Sci. USA 108, 9601–9606 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745–757 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179–185 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Hu, B. et al. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc. Natl Acad. Sci. USA http://dx.doi.org/10.1073/pnas.1307575110 (2013). This paper, together with reference 103, shows that the intestinal dysbiosis that results from innate immune deficiency leads to transmissible colon cancer.
• Sobhani, I. et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 6, e16393 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Marchesi, J. R. et al. Towards the human colorectal cancer microbiome. PLoS ONE 6, e20447 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299–306 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292–298 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Strauss, J. et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm. Bowel Dis. 17, 1971–1978 (2011).
  Article PubMed Google Scholar
• Kostic, A. D. et al. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment. Cell Host Microbe. 14, 207–215 (2013)
  Article CAS PubMed PubMed Central Google Scholar
• Rubinstein, M. R., et al. Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin. Cell Host Microbe. 14, 195–206 (2013)
  Article CAS PubMed PubMed Central Google Scholar
• Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nature Med. 15, 1016–1022 (2009). This paper shows the direct involvement of a member of the commensal microflora in inflammation and tumorigenesis.
  Article CAS PubMed Google Scholar
• Dapito, D. H. et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21, 504–516 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Yoshimoto, S. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97–101 (2013). This report links microbiota-derived products to carcinogenesis and cellular senescence.
  Article CAS PubMed Google Scholar
• Yusuf, N. et al. Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis. Cancer Res. 68, 615–622 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Swann, J. B. et al. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc. Natl Acad. Sci. USA 105, 652–656 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Nickoloff, B. J., Ben-Neriah, Y. & Pikarsky, E. Inflammation and cancer: is the link as simple as we think?. J. Invest Dermatol. 124, 10–14 (2005).
  Article Google Scholar
• Sanders, M. E. et al. An update on the use and investigation of probiotics in health and disease. Gut 62, 787–796 (2013).
  Article CAS PubMed Google Scholar
• Maroof, H., Hassan, Z. M., Mobarez, A. M. & Mohamadabadi, M. A. Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J. Clin. Immunol. 32, 1353–1359 (2012).
  Article CAS PubMed Google Scholar
• Bassaganya-Riera, J., Viladomiu, M., Pedragosa, M., De Simone, C. & Hontecillas, R. Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PLoS ONE 7, e34676 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Corthesy, B., Gaskins, H. R. & Mercenier, A. Cross-talk between probiotic bacteria and the host immune system. J. Nutr. 137, 781S–790S (2007).
  Article CAS PubMed Google Scholar
• Orlando, A., Messa, C., Linsalata, M., Cavallini, A. & Russo, F. Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines. Immunopharmacol. Immunotoxicol 31, 108–116 (2009).
  Article CAS PubMed Google Scholar
• Kim, Y. et al. Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212. Arch. Pharm. Res. 31, 468–473 (2008).
  Article CAS PubMed Google Scholar
• Le Leu, R. K. et al. A synbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen- damaged cells in rat colon. J. Nutr. 135, 996–1001 (2005).
  Article CAS PubMed Google Scholar
• Pool-Zobel, B. L. et al. _Lactobacillus_- and bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr. Cancer 26, 365–380 (1996).
  Article CAS PubMed Google Scholar